Prognostic role of cyclin D1 in retroperitoneal sarcomas

S. H. Kim, N. H. Cho, G. Tallini, M. Dudas, J. J. Lewis, C. Cordon-Cardo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

PURPOSE. Cyclin D1 regulates the G1 checkpoint of the cell cycle and is overexpressed in a number of cancers. This study was designed to determine if cyclin D1 overexpression had prognostic value in patients undergoing surgery with curative intent for primary retroperitoneal soft-tissue sarcoma. METHODS. Tissue was available for analysis on 79 patients who underwent resection between September 1983 and May 1997. Clinicopathologic data and follow-up was obtained from a prospective sarcoma database and a patient and family interview. Immunohistochemical analysis was used to determine overexpression (≥ 5% of nuclei labeled). Survival was analyzed using the Kaplan-Meier method, and statistical analysis was performed by using log rank testing and the Cox regression model. RESULTS. Median follow-up was 3.5 years. On univariate analysis of disease-specific mortality, significant prognostic factors were high grade (n = 42, 53%), positive microscopic margins (n = 36, 46%) or macroscopic margins (n = 15, 19%), and cyclin D1 overexpression (n = 37, 47%). On multivariate analysis, macroscopically positive margins (P = 0.02) and the combination of high grade and cyclin D1 overexpression (P = 0.04) both were associated independently with poor survival. CONCLUSION. High grade retroperitoneal sarcomas demonstrating cyclin D1 overexpression have had an extremely poor prognosis. Continued study of multiple biological markers, exemplified by cyclin D1, may aid characterization of tumor behavior and response to treatment in this diverse group of tumors.

Original languageEnglish
Pages (from-to)428-434
Number of pages7
JournalCancer
Volume91
Issue number2
DOIs
Publication statusPublished - 2001 Jan 15

Fingerprint

Cyclin D1
Sarcoma
G1 Phase Cell Cycle Checkpoints
Neoplasms
Survival
Proportional Hazards Models
Multivariate Analysis
Biomarkers
Databases
Interviews
Mortality

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kim, S. H. ; Cho, N. H. ; Tallini, G. ; Dudas, M. ; Lewis, J. J. ; Cordon-Cardo, C. / Prognostic role of cyclin D1 in retroperitoneal sarcomas. In: Cancer. 2001 ; Vol. 91, No. 2. pp. 428-434.
@article{871c361e13ac4e77a878f1952a2629d4,
title = "Prognostic role of cyclin D1 in retroperitoneal sarcomas",
abstract = "PURPOSE. Cyclin D1 regulates the G1 checkpoint of the cell cycle and is overexpressed in a number of cancers. This study was designed to determine if cyclin D1 overexpression had prognostic value in patients undergoing surgery with curative intent for primary retroperitoneal soft-tissue sarcoma. METHODS. Tissue was available for analysis on 79 patients who underwent resection between September 1983 and May 1997. Clinicopathologic data and follow-up was obtained from a prospective sarcoma database and a patient and family interview. Immunohistochemical analysis was used to determine overexpression (≥ 5{\%} of nuclei labeled). Survival was analyzed using the Kaplan-Meier method, and statistical analysis was performed by using log rank testing and the Cox regression model. RESULTS. Median follow-up was 3.5 years. On univariate analysis of disease-specific mortality, significant prognostic factors were high grade (n = 42, 53{\%}), positive microscopic margins (n = 36, 46{\%}) or macroscopic margins (n = 15, 19{\%}), and cyclin D1 overexpression (n = 37, 47{\%}). On multivariate analysis, macroscopically positive margins (P = 0.02) and the combination of high grade and cyclin D1 overexpression (P = 0.04) both were associated independently with poor survival. CONCLUSION. High grade retroperitoneal sarcomas demonstrating cyclin D1 overexpression have had an extremely poor prognosis. Continued study of multiple biological markers, exemplified by cyclin D1, may aid characterization of tumor behavior and response to treatment in this diverse group of tumors.",
author = "Kim, {S. H.} and Cho, {N. H.} and G. Tallini and M. Dudas and Lewis, {J. J.} and C. Cordon-Cardo",
year = "2001",
month = "1",
day = "15",
doi = "10.1002/1097-0142(20010115)91:2<428::AID-CNCR1018>3.0.CO;2-#",
language = "English",
volume = "91",
pages = "428--434",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

Kim, SH, Cho, NH, Tallini, G, Dudas, M, Lewis, JJ & Cordon-Cardo, C 2001, 'Prognostic role of cyclin D1 in retroperitoneal sarcomas', Cancer, vol. 91, no. 2, pp. 428-434. https://doi.org/10.1002/1097-0142(20010115)91:2<428::AID-CNCR1018>3.0.CO;2-#

Prognostic role of cyclin D1 in retroperitoneal sarcomas. / Kim, S. H.; Cho, N. H.; Tallini, G.; Dudas, M.; Lewis, J. J.; Cordon-Cardo, C.

In: Cancer, Vol. 91, No. 2, 15.01.2001, p. 428-434.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic role of cyclin D1 in retroperitoneal sarcomas

AU - Kim, S. H.

AU - Cho, N. H.

AU - Tallini, G.

AU - Dudas, M.

AU - Lewis, J. J.

AU - Cordon-Cardo, C.

PY - 2001/1/15

Y1 - 2001/1/15

N2 - PURPOSE. Cyclin D1 regulates the G1 checkpoint of the cell cycle and is overexpressed in a number of cancers. This study was designed to determine if cyclin D1 overexpression had prognostic value in patients undergoing surgery with curative intent for primary retroperitoneal soft-tissue sarcoma. METHODS. Tissue was available for analysis on 79 patients who underwent resection between September 1983 and May 1997. Clinicopathologic data and follow-up was obtained from a prospective sarcoma database and a patient and family interview. Immunohistochemical analysis was used to determine overexpression (≥ 5% of nuclei labeled). Survival was analyzed using the Kaplan-Meier method, and statistical analysis was performed by using log rank testing and the Cox regression model. RESULTS. Median follow-up was 3.5 years. On univariate analysis of disease-specific mortality, significant prognostic factors were high grade (n = 42, 53%), positive microscopic margins (n = 36, 46%) or macroscopic margins (n = 15, 19%), and cyclin D1 overexpression (n = 37, 47%). On multivariate analysis, macroscopically positive margins (P = 0.02) and the combination of high grade and cyclin D1 overexpression (P = 0.04) both were associated independently with poor survival. CONCLUSION. High grade retroperitoneal sarcomas demonstrating cyclin D1 overexpression have had an extremely poor prognosis. Continued study of multiple biological markers, exemplified by cyclin D1, may aid characterization of tumor behavior and response to treatment in this diverse group of tumors.

AB - PURPOSE. Cyclin D1 regulates the G1 checkpoint of the cell cycle and is overexpressed in a number of cancers. This study was designed to determine if cyclin D1 overexpression had prognostic value in patients undergoing surgery with curative intent for primary retroperitoneal soft-tissue sarcoma. METHODS. Tissue was available for analysis on 79 patients who underwent resection between September 1983 and May 1997. Clinicopathologic data and follow-up was obtained from a prospective sarcoma database and a patient and family interview. Immunohistochemical analysis was used to determine overexpression (≥ 5% of nuclei labeled). Survival was analyzed using the Kaplan-Meier method, and statistical analysis was performed by using log rank testing and the Cox regression model. RESULTS. Median follow-up was 3.5 years. On univariate analysis of disease-specific mortality, significant prognostic factors were high grade (n = 42, 53%), positive microscopic margins (n = 36, 46%) or macroscopic margins (n = 15, 19%), and cyclin D1 overexpression (n = 37, 47%). On multivariate analysis, macroscopically positive margins (P = 0.02) and the combination of high grade and cyclin D1 overexpression (P = 0.04) both were associated independently with poor survival. CONCLUSION. High grade retroperitoneal sarcomas demonstrating cyclin D1 overexpression have had an extremely poor prognosis. Continued study of multiple biological markers, exemplified by cyclin D1, may aid characterization of tumor behavior and response to treatment in this diverse group of tumors.

UR - http://www.scopus.com/inward/record.url?scp=0035863131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035863131&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(20010115)91:2<428::AID-CNCR1018>3.0.CO;2-#

DO - 10.1002/1097-0142(20010115)91:2<428::AID-CNCR1018>3.0.CO;2-#

M3 - Article

C2 - 11180091

AN - SCOPUS:0035863131

VL - 91

SP - 428

EP - 434

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -